Recombinant Human Coagulation Factor Ⅷ for Injection

Recombinant human coagulation factor VIIa for injection is indicated for the treatment of bleeding episodes and prevention of bleeding during surgical procedures or invasive procedures in the following patient groups: · Congenital hemophilia patients with inhibitors of coagulation factor VIII or IX >5BU; · Congenital hemophilia patients who are expected to have a high memory response to injection of coagulation factor VIII or coagulation factor IX; · Acquired hemophilia patients; · Congenital FVII deficiency patients; · Thrombasthenia patients with GPⅡb-Ⅲa and/or HLA antibodies and who have been or are currently ineffective or poorly responsive to platelet transfusions